Azamian Bobak R. — SEC Form 4 filings

SEC reporting owner CIK 1827672. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2024-03-11 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Tarsus Pharmaceuticals, Inc. (TARS)President/CEO and Board Chair, Director1617 legs · 123,234 sh · $7,595,65119

Form 4 filings — Azamian Bobak R.

FiledFormIssuerReported transactionsSource
2026-09-094Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 7,100 @ $90.27 · Sale (S): 2,900 @ $91.27EDGAR
2026-09-034Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 10,000 @ $80.06EDGAR
2026-06-224Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 4,582 @ $61.24 · Sale (S): 5,418 @ $61.81EDGAR
2026-03-194Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 10,972 @ $69.42 · Sale (S): 11,667 @ $68.71 · Sale (S): 11,964 @ $67EDGAR
2026-03-174Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 66,274 · Option exercise (M): 11,300 (derivative) @ $0 · Option exercise (M): 16,975 (derivative) @ $0 · Option exercise (M): 23,121 (derivative) @ $0 · Option exercise (M): 14,878 (derivative) @ $0EDGAR
2026-03-094Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 96,723 (derivative) @ $0 · Grant/award (A): 60,776 (derivative) @ $0EDGAR
2025-12-304Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 5,443 @ $82.41 · Sale (S): 557 @ $83.54EDGAR
2025-12-084Tarsus Pharmaceuticals, Inc. (TARS)Gift (G): 51,885 @ $0EDGAR
2025-09-264Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 6,000 @ $55.37EDGAR
2025-08-134Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 6,000 @ $50EDGAR
2025-03-264Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 6,000 @ $50EDGAR
2025-03-204Tarsus Pharmaceuticals, Inc. (TARS)Sale (S): 7,131 @ $46.29 · Sale (S): 8,551 @ $47.40 · Sale (S): 8,534 @ $50.11EDGAR
2025-03-184Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 51,395 · Option exercise (M): 11,299 (derivative) @ $0 · Option exercise (M): 16,975 (derivative) @ $0 · Option exercise (M): 23,121 (derivative) @ $0EDGAR
2025-03-074Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 90,736 (derivative) @ $0 · Grant/award (A): 59,512 (derivative) @ $0EDGAR
2024-03-194Tarsus Pharmaceuticals, Inc. (TARS)Option exercise (M): 28,274 · Sale (S): 10,415 @ $30.60 · Option exercise (M): 11,299 (derivative) @ $0 · Option exercise (M): 16,975 (derivative) @ $0EDGAR
2024-03-114Tarsus Pharmaceuticals, Inc. (TARS)Grant/award (A): 136,947 (derivative) @ $0 · Grant/award (A): 92,485 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1827672 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →